Amphastar Pharmaceuticals, Inc. Income Taxes Paid
Amphastar Pharmaceuticals, Inc. (AMPH) reported Income Taxes Paid of $22.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-26
- Amphastar Pharmaceuticals, Inc. income taxes paid for the quarter ending 2025-12-31 was $402.00K, a 96.38% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. income taxes paid for the quarter ending 2025-09-30 was $10.00K, a 99.92% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. income taxes paid for the quarter ending 2024-12-31 was $11.10M, a 76.31% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. income taxes paid for the quarter ending 2024-09-30 was $12.07M, a 1382.56% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. income taxes paid for fiscal 2025 was $22.71M, a 43.37% decline from fiscal 2024.
- Amphastar Pharmaceuticals, Inc. income taxes paid for fiscal 2024 was $40.10M, a 18.16% decline from fiscal 2023.
- Amphastar Pharmaceuticals, Inc. income taxes paid for fiscal 2023 was $49.00M, a 10.26% increase from fiscal 2022.
- Amphastar Pharmaceuticals, Inc. income taxes paid for fiscal 2022 was $44.44M, a 448.94% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $412.00K derived: sum of 2 quarters · filed 2026-02-26 | $22.71M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $22.31M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $22.30M 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.17M derived: sum of 2 quarters · filed 2026-02-26 | $39.76M derived: sum of 3 quarters · filed 2026-02-26 | $40.10M 10-K · filed 2026-02-26 |
| 2024-09-30 | $12.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $28.65M derived: sum of 2 quarters · filed 2025-11-06 | $29.00M 10-Q · filed 2025-11-06 | $75.86M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $16.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $16.93M 10-Q · filed 2025-08-07 | $63.80M derived: sum of 3 quarters · filed 2026-02-26 | $64.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $349.00K 10-Q · filed 2024-05-10 | $47.21M derived: sum of 2 quarters · filed 2026-02-26 | $48.03M derived: sum of 3 quarters · filed 2026-02-26 | $49.01M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $46.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $47.68M derived: sum of 2 quarters · filed 2026-02-26 | $48.66M derived: sum of 3 quarters · filed 2026-02-26 | $49.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $814.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.80M derived: sum of 2 quarters · filed 2024-11-07 | $2.14M 10-Q · filed 2024-11-07 | $11.41M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.32M 10-Q · filed 2024-08-09 | $10.60M derived: sum of 3 quarters · filed 2025-03-03 | $21.80M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $336.00K 10-Q · filed 2024-05-10 | $9.61M derived: sum of 2 quarters · filed 2025-03-03 | $20.81M derived: sum of 3 quarters · filed 2025-03-03 | $44.59M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $20.48M derived: sum of 2 quarters · filed 2025-03-03 | $44.26M derived: sum of 3 quarters · filed 2025-03-03 | $44.44M 10-K · filed 2025-03-03 |
| 2022-09-30 | $11.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $34.98M derived: sum of 2 quarters · filed 2023-11-08 | $35.17M 10-Q · filed 2023-11-08 | $37.78M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $23.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $23.96M 10-Q · filed 2023-08-09 | $26.58M derived: sum of 3 quarters · filed 2024-02-29 | $27.48M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $183.00K 10-Q · filed 2023-05-09 | $2.80M derived: sum of 2 quarters · filed 2024-02-29 | $3.70M derived: sum of 3 quarters · filed 2024-02-29 | $8.25M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.52M derived: sum of 2 quarters · filed 2024-02-29 | $8.07M derived: sum of 3 quarters · filed 2024-02-29 | $8.10M 10-K · filed 2024-02-29 |
| 2021-09-30 | $903.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.45M derived: sum of 2 quarters · filed 2022-11-08 | $5.48M 10-Q · filed 2022-11-08 | $6.08M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $4.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.58M 10-Q · filed 2022-08-09 | $5.18M derived: sum of 3 quarters · filed 2023-03-01 | $7.33M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $30.00K 10-Q · filed 2022-05-10 | $634.00K derived: sum of 2 quarters · filed 2023-03-01 | $2.78M derived: sum of 3 quarters · filed 2023-03-01 | $3.23M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.75M derived: sum of 2 quarters · filed 2023-03-01 | $3.20M derived: sum of 3 quarters · filed 2023-03-01 | $3.41M 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.60M derived: sum of 2 quarters · filed 2021-11-09 | $2.81M 10-Q · filed 2021-11-09 | $4.33M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | $453.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $662.00K 10-Q · filed 2021-08-09 | $2.19M derived: sum of 3 quarters · filed 2022-03-11 | $5.23M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-03-31 | $209.00K 10-Q · filed 2021-05-07 | $1.74M derived: sum of 2 quarters · filed 2022-03-11 | $4.78M derived: sum of 3 quarters · filed 2022-03-11 | $5.69M derived: sum of 4 quarters · filed 2022-03-11 |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $4.57M derived: sum of 2 quarters · filed 2022-03-11 | $5.48M derived: sum of 3 quarters · filed 2022-03-11 | $5.72M 10-K · filed 2022-03-11 |
| 2019-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.96M derived: sum of 2 quarters · filed 2020-11-06 | $4.19M 10-Q · filed 2020-11-06 | $4.37M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $913.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.15M 10-Q · filed 2020-08-07 | $1.32M derived: sum of 3 quarters · filed 2021-03-15 | $1.34M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $234.00K 10-Q · filed 2020-05-11 | $410.00K derived: sum of 2 quarters · filed 2021-03-15 | $424.00K derived: sum of 3 quarters · filed 2021-03-15 | $565.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $190.00K derived: sum of 2 quarters · filed 2021-03-15 | $331.00K derived: sum of 3 quarters · filed 2021-03-15 | $339.00K 10-K · filed 2021-03-15 |
| 2018-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $155.00K derived: sum of 2 quarters · filed 2019-11-08 | $163.00K 10-Q · filed 2019-11-08 | $163.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $149.00K 10-Q · filed 2019-08-09 | $149.00K derived: sum of 3 quarters · filed 2020-03-16 | $456.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $8.00K 10-Q · filed 2019-05-10 | $8.00K derived: sum of 2 quarters · filed 2020-03-16 | $315.00K derived: sum of 3 quarters · filed 2020-03-16 | $4.44M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $307.00K derived: sum of 2 quarters · filed 2020-03-16 | $4.44M derived: sum of 3 quarters · filed 2020-03-16 | $4.88M 10-K · filed 2020-03-16 |
| 2017-09-30 | $307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $4.44M derived: sum of 2 quarters · filed 2018-11-09 | $4.88M 10-Q · filed 2018-11-09 | $5.01M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.57M 10-Q · filed 2018-08-09 | $4.70M derived: sum of 3 quarters · filed 2019-03-15 | $7.41M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $440.00K 10-Q · filed 2018-05-10 | $574.00K derived: sum of 2 quarters · filed 2019-03-15 | $3.28M derived: sum of 3 quarters · filed 2019-03-15 | $3.47M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $2.84M derived: sum of 2 quarters · filed 2019-03-15 | $3.03M derived: sum of 3 quarters · filed 2019-03-15 | $3.40M 10-K · filed 2019-03-15 |
| 2016-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.90M derived: sum of 2 quarters · filed 2017-11-09 | $3.26M 10-Q · filed 2017-11-09 | $3.36M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $553.00K 10-Q · filed 2017-08-09 | $654.00K derived: sum of 3 quarters · filed 2018-03-14 | |
| 2016-03-31 | $367.00K 10-Q · filed 2017-05-10 | $468.00K derived: sum of 2 quarters · filed 2018-03-14 | ||
| 2015-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $146.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $45.00K 10-Q · filed 2016-11-09 | |||
| 2014-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $352.00K derived: sum of 2 quarters · filed 2017-03-15 | $357.00K derived: sum of 3 quarters · filed 2017-03-15 | $436.00K 10-K · filed 2017-03-15 |
| 2014-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $7.00K derived: sum of 2 quarters · filed 2015-11-13 | $86.00K 10-Q · filed 2015-11-13 | $227.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $84.00K 10-Q · filed 2015-08-13 | $225.00K derived: sum of 3 quarters · filed 2016-03-15 | $4.17M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $79.00K 10-Q · filed 2015-05-14 | $220.00K derived: sum of 2 quarters · filed 2016-03-15 | $4.16M derived: sum of 3 quarters · filed 2016-03-15 | |
| 2013-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $4.08M derived: sum of 2 quarters · filed 2016-03-15 | $4.16M 10-K · filed 2016-03-15 | |
| 2013-09-30 | $3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $4.02M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $75.00K 10-Q · filed 2014-08-13 | |||
| 2012-12-31 | $2.08M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |